Fernando de Andrés-Nogales (F de Andrés-Nogales)

Years Active: 2020-2021
Publications (10 Years): 3

Pharmacoeconomics & Outcomes Research Iberia

Universidad Carlos III de Madrid (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pharmacoeconomics & Outcomes Research Iberia Jul 14 2011

Spain

Health Economics & Outcomes Research Analyst

Education History

Universidad Carlos III de Madrid

Spain

MSC :: Department of Economy

Centro de Estudios Superiores de la Industria Farmacéutica

Spain

MSC

Universidad Complutense de Madrid

Spain

BSC

Publications

Carlos Taxonera, Fernando de Andrés-Nogales, Santiago García-López, Amelia Sánchez-Guerrero, Belén Menchén, Carmen Peral, Ana Cábez, Susana Gómez, Alejandra López-Ibáñez de Aldecoa, Miguel Ángel Casado, Luis Menchén
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain. Expert review of pharmacoeconomics & outcomes research (2021)
Fernando de Andrés-Nogales, Encarnación Cruz, Miguel Ángel Calleja, Olga Delgado, Maria Queralt Gorgas, Jaime Espín, Jorge Mestre-Ferrándiz, Francesc Palau, Alba Ancochea, Rosabel Arce, Raquel Domínguez-Hernández, Miguel Ángel Casado, null null
A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study). Orphanet journal of rare diseases 16 (1) (2021)
J M Ruiz-Moreno, Fernando de Andrés-Nogales, Itziar Oyagüez
Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients. BMC ophthalmology 20 (1) (2020)

Fernando de Andrés-Nogales.css-eqlu8i{font-size:small;padding-left:4px;} (F de Andrés-Nogales)